Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,654 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-effectiveness of a Novel Hypoglycaemia Programme: The 'HARPdoc vs BGAT' RCT.
Healey A, Soukup T, Sevdalis N, Bakolis I, Cross S, Heller SR, Brooks A, Kariyawasam D, Toschi E, Gonder-Frederick L, Stadler M, Rogers H, Goldsmith K, Choudhary P, de Zoysa N, Amiel SA; HARPdoc RCT Study Group. Healey A, et al. Among authors: brooks a. Diabet Med. 2024 Jun;41(6):e15304. doi: 10.1111/dme.15304. Epub 2024 Feb 29. Diabet Med. 2024. PMID: 38421806 Clinical Trial.
Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions.
Amiel SA, Choudhary P, Jacob P, Smith EL, De Zoysa N, Gonder-Frederick L, Kendall M, Heller S, Brooks A, Toschi E, Kariyawasam D, Potts L, Healy A, Rogers H, Sevdalis N, Stadler M, Qayyum M, Bakolis I, Goldsmith K. Amiel SA, et al. Among authors: brooks a. BMJ Open. 2019 Jun 16;9(6):e030356. doi: 10.1136/bmjopen-2019-030356. BMJ Open. 2019. PMID: 31209097 Free PMC article.
Predictors of Recurrent Severe Hypoglycemia in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia During the HypoCOMPaSS Study.
Flatt AJS, Little SA, Speight J, Leelarathna L, Walkinshaw E, Tan HK, Bowes A, Lubina-Solomon A, Holmes-Truscott E, Chadwick TJ, Wood R, McDonald TJ, Kerr D, Flanagan D, Brooks A, Heller SR, Evans ML, Shaw JAM. Flatt AJS, et al. Among authors: brooks a. Diabetes Care. 2020 Jan;43(1):44-52. doi: 10.2337/dc19-0630. Epub 2019 Sep 4. Diabetes Care. 2020. PMID: 31484666 Clinical Trial.
Characteristics of adults with type 1 diabetes and treatment-resistant problematic hypoglycaemia: a baseline analysis from the HARPdoc RCT.
Jacob P, Potts L, Maclean RH, de Zoysa N, Rogers H, Gonder-Frederick L, Smith EL, Kariyawasam D, Brooks A, Heller S, Toschi E, Kendall M, Bakolis I, Choudhary P, Goldsmith K, Amiel SA; HARPdoc study group. Jacob P, et al. Among authors: brooks a. Diabetologia. 2022 Jun;65(6):936-948. doi: 10.1007/s00125-022-05679-5. Epub 2022 Mar 24. Diabetologia. 2022. PMID: 35325258 Free PMC article. Clinical Trial.
A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc).
Amiel SA, Potts L, Goldsmith K, Jacob P, Smith EL, Gonder-Frederick L, Heller S, Toschi E, Brooks A, Kariyawasam D, Choudhary P, Stadler M, Rogers H, Kendall M, Sevdalis N, Bakolis I, de Zoysa N. Amiel SA, et al. Among authors: brooks a. Nat Commun. 2022 Apr 28;13(1):2229. doi: 10.1038/s41467-022-29488-x. Nat Commun. 2022. PMID: 35484106 Free PMC article. Clinical Trial.
Attainment of metabolic goals in the integrated UK islet transplant program with locally isolated and transported preparations.
Brooks AM, Walker N, Aldibbiat A, Hughes S, Jones G, de Havilland J, Choudhary P, Huang GC, Parrott N, McGowan NW, Casey J, Mumford L, Barker P, Burling K, Hovorka R, Walker M, Smith RM, Forbes S, Rutter MK, Amiel S, Rosenthal MJ, Johnson P, Shaw JA. Brooks AM, et al. Am J Transplant. 2013 Dec;13(12):3236-43. doi: 10.1111/ajt.12469. Epub 2013 Oct 1. Am J Transplant. 2013. PMID: 24119216 Free article.
Autoreactive T cell profiles are altered following allogeneic islet transplantation with alemtuzumab induction and re-emerging phenotype is associated with graft function.
Sabbah S, Liew A, Brooks AM, Kundu R, Reading JL, Flatt A, Counter C, Choudhary P, Forbes S, Rosenthal MJ, Rutter MK, Cairns S, Johnson P, Casey J, Peakman M, Shaw JA, Tree TIM. Sabbah S, et al. Among authors: brooks am. Am J Transplant. 2021 Mar;21(3):1027-1038. doi: 10.1111/ajt.16285. Epub 2020 Sep 19. Am J Transplant. 2021. PMID: 32865886 Free article.
2,654 results